A Research Study For People With Painful Diabetic Peripheral Neuropathy (DPN) is Now Enrolling
The purpose of this study is to evaluate investigational tapentadol extended release (ER) when compared to placebo. Placebo is a dummy pill with no active drug, but looks like the real drug. Tapentadol is an opiod (narcotic) drug. Tapentadol immediate release (IR) has already been approved in does of 50, 75, and 100 mg for relief of moderate to severe pain. Participation in this 5-month study requires 14 office visits and 1 follow-up call. Researchers will be evaluating:
Inclusion Criteria:
Exclusion Criteria:
Condition | Neuropathy |
---|---|
Clinical Study Identifier | TX134975 |
Last Modified on | 21 April 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.